Intrinsic Value
BioCryst Pharmaceuticals, Inc. (BCRX)
$4.5
-0.08 (-1.75%)
| Enterprise Value | -1,382,851.66 |
|---|---|
| Net Debt | 736.27 |
| Equity Value | -1,383,587.93 |
| Shares Outstanding | 192.20 |
| Equity Value Per Share | -7,198.76 |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt